Cesar Compadre
Concepts (175)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asteraceae | 3 | 2022 | 10 | 1.600 |
Why?
| | Lactones | 3 | 2020 | 25 | 1.510 |
Why?
| | Sesquiterpenes | 3 | 2020 | 89 | 1.420 |
Why?
| | Leukocytes, Mononuclear | 2 | 2020 | 122 | 0.770 |
Why?
| | Vitamin E | 2 | 2013 | 77 | 0.740 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2020 | 202 | 0.690 |
Why?
| | Yoga | 1 | 2021 | 15 | 0.680 |
Why?
| | Pharmaceutical Services | 1 | 2021 | 52 | 0.660 |
Why?
| | Pharmacy | 1 | 2021 | 54 | 0.640 |
Why?
| | Students, Pharmacy | 1 | 2021 | 130 | 0.590 |
Why?
| | Education, Pharmacy | 1 | 2021 | 156 | 0.570 |
Why?
| | Tocotrienols | 2 | 2013 | 37 | 0.510 |
Why?
| | Anti-Bacterial Agents | 4 | 2012 | 816 | 0.510 |
Why?
| | Cell Proliferation | 1 | 2020 | 1013 | 0.510 |
Why?
| | Staphylococcus aureus | 3 | 2012 | 312 | 0.440 |
Why?
| | Radiation-Protective Agents | 2 | 2013 | 69 | 0.420 |
Why?
| | Cell Death | 2 | 2012 | 169 | 0.370 |
Why?
| | Carrier Proteins | 1 | 2013 | 312 | 0.360 |
Why?
| | Chromans | 1 | 2011 | 34 | 0.360 |
Why?
| | Methicillin Resistance | 1 | 2011 | 16 | 0.360 |
Why?
| | Kidney Tubules, Proximal | 1 | 2011 | 60 | 0.360 |
Why?
| | Liver | 1 | 2013 | 1150 | 0.280 |
Why?
| | Mitochondria | 1 | 2011 | 420 | 0.280 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 1216 | 0.270 |
Why?
| | Oxidative Stress | 1 | 2011 | 805 | 0.260 |
Why?
| | Plant Extracts | 3 | 2022 | 199 | 0.260 |
Why?
| | Models, Molecular | 5 | 2013 | 356 | 0.250 |
Why?
| | Crystallography, X-Ray | 2 | 2020 | 158 | 0.250 |
Why?
| | Pyridinium Compounds | 1 | 2005 | 20 | 0.240 |
Why?
| | Quantitative Structure-Activity Relationship | 1 | 2005 | 32 | 0.230 |
Why?
| | Cetylpyridinium | 1 | 2005 | 2 | 0.230 |
Why?
| | Malus | 1 | 2005 | 5 | 0.230 |
Why?
| | Drug Residues | 1 | 2005 | 8 | 0.230 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 106 | 0.210 |
Why?
| | Molecular Structure | 2 | 2016 | 317 | 0.200 |
Why?
| | Chromatography, Thin Layer | 1 | 2022 | 20 | 0.190 |
Why?
| | Plants | 1 | 2022 | 28 | 0.190 |
Why?
| | Tyramine | 1 | 2020 | 4 | 0.170 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2020 | 17 | 0.170 |
Why?
| | Heme Oxygenase-1 | 1 | 2020 | 18 | 0.170 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2020 | 31 | 0.170 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2020 | 71 | 0.160 |
Why?
| | Morpholines | 1 | 2020 | 64 | 0.160 |
Why?
| | Piperidines | 1 | 2020 | 99 | 0.160 |
Why?
| | Microbial Sensitivity Tests | 3 | 2012 | 271 | 0.160 |
Why?
| | Drug Design | 2 | 2013 | 122 | 0.160 |
Why?
| | Profilins | 1 | 2017 | 13 | 0.130 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2017 | 36 | 0.130 |
Why?
| | Cell Line, Tumor | 1 | 2020 | 1429 | 0.130 |
Why?
| | Ecuador | 1 | 2016 | 4 | 0.120 |
Why?
| | Mutation, Missense | 1 | 2017 | 108 | 0.120 |
Why?
| | HL-60 Cells | 1 | 2016 | 19 | 0.120 |
Why?
| | Medicine, Traditional | 1 | 2016 | 17 | 0.120 |
Why?
| | Spinal Cord | 1 | 2017 | 169 | 0.120 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2016 | 135 | 0.120 |
Why?
| | HeLa Cells | 1 | 2016 | 243 | 0.120 |
Why?
| | Humans | 10 | 2021 | 52441 | 0.120 |
Why?
| | Biological Availability | 2 | 2013 | 107 | 0.120 |
Why?
| | Blotting, Western | 1 | 2016 | 587 | 0.110 |
Why?
| | Nuclear Family | 1 | 2014 | 16 | 0.110 |
Why?
| | Half-Life | 1 | 2013 | 86 | 0.100 |
Why?
| | Molecular Dynamics Simulation | 1 | 2013 | 44 | 0.100 |
Why?
| | Pentoxifylline | 1 | 2013 | 13 | 0.100 |
Why?
| | Biofilms | 2 | 2012 | 183 | 0.100 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2013 | 25 | 0.100 |
Why?
| | Rats, Wistar | 1 | 2013 | 223 | 0.100 |
Why?
| | Animals | 6 | 2017 | 13485 | 0.100 |
Why?
| | Quercus | 1 | 2012 | 9 | 0.100 |
Why?
| | Binding Sites | 1 | 2013 | 379 | 0.100 |
Why?
| | Students | 1 | 2014 | 230 | 0.090 |
Why?
| | United States | 2 | 2021 | 5215 | 0.090 |
Why?
| | Ellagic Acid | 1 | 2012 | 6 | 0.090 |
Why?
| | Rosaceae | 1 | 2012 | 9 | 0.090 |
Why?
| | tert-Butylhydroperoxide | 1 | 2011 | 4 | 0.090 |
Why?
| | Oligomycins | 1 | 2011 | 8 | 0.090 |
Why?
| | alpha-Tocopherol | 1 | 2011 | 9 | 0.090 |
Why?
| | Proton-Translocating ATPases | 1 | 2011 | 10 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 23 | 0.090 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2011 | 43 | 0.090 |
Why?
| | Cell Respiration | 1 | 2011 | 42 | 0.090 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2011 | 64 | 0.090 |
Why?
| | Plant Components, Aerial | 1 | 2011 | 5 | 0.090 |
Why?
| | Oxidative Phosphorylation | 1 | 2011 | 46 | 0.090 |
Why?
| | Inhibitory Concentration 50 | 1 | 2011 | 74 | 0.090 |
Why?
| | Rabbits | 1 | 2011 | 370 | 0.090 |
Why?
| | Smoking | 1 | 2014 | 514 | 0.080 |
Why?
| | Rats | 2 | 2013 | 3228 | 0.080 |
Why?
| | Heart | 1 | 2013 | 352 | 0.080 |
Why?
| | Oxygen Consumption | 1 | 2011 | 193 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2011 | 249 | 0.080 |
Why?
| | Adenosine Triphosphate | 1 | 2011 | 234 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2011 | 217 | 0.080 |
Why?
| | Cell Survival | 1 | 2011 | 598 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 415 | 0.080 |
Why?
| | Brain | 1 | 2017 | 1337 | 0.070 |
Why?
| | Cells, Cultured | 1 | 2011 | 1583 | 0.070 |
Why?
| | Apoptosis | 1 | 2011 | 1120 | 0.060 |
Why?
| | Food Preservatives | 1 | 2005 | 3 | 0.060 |
Why?
| | Salmonella typhimurium | 1 | 2005 | 40 | 0.060 |
Why?
| | Food Microbiology | 1 | 2005 | 41 | 0.060 |
Why?
| | Calibration | 1 | 2005 | 56 | 0.060 |
Why?
| | Escherichia coli | 1 | 2005 | 182 | 0.050 |
Why?
| | Software | 1 | 2005 | 281 | 0.050 |
Why?
| | Aerosol Propellants | 1 | 2003 | 2 | 0.050 |
Why?
| | Receptors, Muscarinic | 1 | 2002 | 18 | 0.050 |
Why?
| | Lithocholic Acid | 1 | 2002 | 20 | 0.050 |
Why?
| | Adrenergic beta-Agonists | 1 | 2003 | 39 | 0.050 |
Why?
| | Thymidine Kinase | 1 | 2002 | 18 | 0.050 |
Why?
| | Muscarinic Antagonists | 1 | 2002 | 24 | 0.050 |
Why?
| | Ganciclovir | 1 | 2002 | 23 | 0.050 |
Why?
| | Molecular Mimicry | 1 | 2002 | 35 | 0.050 |
Why?
| | Herpesvirus 1, Human | 1 | 2002 | 14 | 0.050 |
Why?
| | Metered Dose Inhalers | 1 | 2003 | 18 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 871 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2002 | 81 | 0.050 |
Why?
| | Albuterol | 1 | 2003 | 54 | 0.050 |
Why?
| | Phosphorylation | 2 | 2013 | 536 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2017 | 79 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2017 | 566 | 0.030 |
Why?
| | Imitative Behavior | 1 | 2014 | 8 | 0.030 |
Why?
| | District of Columbia | 1 | 2014 | 20 | 0.030 |
Why?
| | Mice | 2 | 2017 | 5899 | 0.030 |
Why?
| | Protein Kinase C-alpha | 1 | 2013 | 10 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 47 | 0.030 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 48 | 0.030 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 38 | 0.030 |
Why?
| | Family | 1 | 2014 | 170 | 0.030 |
Why?
| | Cell Count | 1 | 2013 | 143 | 0.030 |
Why?
| | Mast Cells | 1 | 2013 | 55 | 0.020 |
Why?
| | Plant Stems | 1 | 2012 | 13 | 0.020 |
Why?
| | Drug Interactions | 1 | 2013 | 198 | 0.020 |
Why?
| | Organs at Risk | 1 | 2013 | 75 | 0.020 |
Why?
| | Models, Animal | 1 | 2013 | 230 | 0.020 |
Why?
| | Plant Leaves | 1 | 2012 | 43 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 168 | 0.020 |
Why?
| | Antigens, CD | 1 | 2013 | 213 | 0.020 |
Why?
| | Administration, Oral | 1 | 2013 | 455 | 0.020 |
Why?
| | Radiation Injuries | 1 | 2013 | 114 | 0.020 |
Why?
| | Chemical Fractionation | 1 | 2012 | 17 | 0.020 |
Why?
| | Biological Assay | 1 | 2012 | 38 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2012 | 75 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 1483 | 0.020 |
Why?
| | Fruit | 1 | 2012 | 130 | 0.020 |
Why?
| | Glycosylation | 1 | 2012 | 104 | 0.020 |
Why?
| | Antibiotic Prophylaxis | 1 | 2012 | 63 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2013 | 283 | 0.020 |
Why?
| | Prevalence | 1 | 2014 | 1016 | 0.020 |
Why?
| | Heart Ventricles | 1 | 2013 | 259 | 0.020 |
Why?
| | Female | 1 | 2011 | 28277 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2012 | 245 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2012 | 294 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 1558 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2014 | 1677 | 0.020 |
Why?
| | Cell Line | 1 | 2012 | 1020 | 0.020 |
Why?
| | Young Adult | 1 | 2014 | 4346 | 0.010 |
Why?
| | N-Methylscopolamine | 1 | 2002 | 3 | 0.010 |
Why?
| | Taurolithocholic Acid | 1 | 2002 | 7 | 0.010 |
Why?
| | Receptor, Muscarinic M3 | 1 | 2002 | 7 | 0.010 |
Why?
| | Inositol Phosphates | 1 | 2002 | 14 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 6713 | 0.010 |
Why?
| | Radioligand Assay | 1 | 2002 | 46 | 0.010 |
Why?
| | Acetylcholine | 1 | 2002 | 56 | 0.010 |
Why?
| | CHO Cells | 1 | 2002 | 123 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2002 | 181 | 0.010 |
Why?
| | Cricetinae | 1 | 2002 | 189 | 0.010 |
Why?
| | Area Under Curve | 1 | 2003 | 182 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2002 | 152 | 0.010 |
Why?
| | Child | 1 | 2014 | 7194 | 0.010 |
Why?
| | Genetic Therapy | 1 | 2002 | 127 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2002 | 399 | 0.010 |
Why?
| | Asthma | 1 | 2003 | 313 | 0.010 |
Why?
| | Mutation | 1 | 2002 | 1331 | 0.010 |
Why?
| | Signal Transduction | 1 | 2002 | 1724 | 0.010 |
Why?
| | Male | 1 | 2013 | 26874 | 0.010 |
Why?
| | Neoplasms | 1 | 2002 | 1314 | 0.010 |
Why?
|
|
Compadre's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|